Skip to main content
    1. Home

    • Ferring Pharmaceuticals

    Submitted by bstumbo on
    Extended Bio

    UCB and Ferring Pharmaceuticals entered into a co-promotion agreement in July 2020 to commercialize the prefilled syringe formulation of CIMZIA® (certolizumab pegol) in the United States, specifically for the treatment of Crohn’s Disease (CD). As part of this agreement, Ferring has taken over field medical affairs activities;

    About Ferring Pharmaceuticals: Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. In the United States, Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and orthopedics. You may reach the Ferring Medical Affairs team by phone or email. Hours of operation are:

    • 8:00 AM – 5:30 PM EST (Monday – Friday)
    Pharma Profile
    On